Procyon is a new cancer diagnostics spinout from Queen Mary University of London which has just completed an oversubscribed ...

While the study did not find a “hyperrealism effect” from the AI voices, it did find that voice clones can sound as real as ...

Rapalink-1, the new drug studied by the team, is a next-generation TOR inhibitor currently under investigation for cancer therapy. The researchers found that rapalink-1 not only slowed aspects of ...

Announced at the House of Lords, findings from the paper in The Lancet: Healthy Longevity demonstrate that the intervention, ...

The pioneering study uses a new approach to detect the presence of circulating tumour DNA (ctDNA) to accurately identify ...

A podcast that uncovers London’s hidden Cockney Yiddish culture, hosted by Queen Mary historians Professor Nadia Valman and ...

Queen Mary University of London has partnered with the MassChallenge startup accelerator to offer a new route to impact for ...

The latest Research.com rankings have named four Queen Mary researchers among the top 100 scientists in the UK, recognising ...

Dr Rageshri Dhairyawan has been awarded the Gilead & Kite Campaigner for Health Equity Award at the 2025 Women of the Year ...

“Our findings highlight menopause as a critical turning point for women’s immunity. While ageing affects everyone, the loss ...

Queen Mary University of London and Barking and Dagenham Council have launched a major new partnership to tackle local health ...

Titled ‘Equitable Partnerships for Civic Engagement: A Toolkit for Civic, Community and University Partners ’, the resource ...